Bibliographic Info
GuidelineConsolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach
Year of Publication2021
Issuing InstitutionWHO
Recommendation
Status
Maintained
Recommended in favor
Conditional
Certainty of evidence
Very low
A raltegravir (RAL)-based regimen is recommended as the preferred first-line regimen for neonates
Also Featured In
This recommendation also appears in the following guidelines:
Originally Developed
Guideline
Updated recommendations on first-line and second-line antiretroviral regimens and post-exposure prophylaxis and recommendations on early infant diagnosis of HIV
Year2018
InstitutionWHO